ID
36027
Beschrijving
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the concomitant medication form. It has to be filled in if the subject takes concomitant medication during the study trial. Please complete drug section for all drugs (including OTC)/ vaccines taken by mother within 3 months prior or during pregnancy.
Trefwoorden
Versies (1)
- 09-04-19 09-04-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
9 april 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Concomitant Medication
- StudyEvent: ODM
Beschrijving
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Beschrijving
If 'YES', please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Experiences Form, utilzing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C2169461
Beschrijving
(Trade Name Preferred)
Datatype
text
Alias
- UMLS CUI [1]
- C2360065
Beschrijving
Single Dose/Unit
Datatype
text
Alias
- UMLS CUI [1]
- C1960417
Beschrijving
Frequency of this Dose
Datatype
text
Alias
- UMLS CUI [1]
- C3476109
Beschrijving
Other routes may be entered onto the form when appropriate, and will be coded prior to data entry.
Datatype
text
Alias
- UMLS CUI [1]
- C0013153
Beschrijving
Indication
Datatype
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Beschrijving
day month year As a minimum the year must be stated.
Datatype
date
Alias
- UMLS CUI [1]
- C2826734
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1]
- C2826740
Beschrijving
day month year
Datatype
date
Alias
- UMLS CUI [1]
- C2826744
Beschrijving
00:00-23:59
Datatype
time
Alias
- UMLS CUI [1]
- C2826659
Beschrijving
Continuing at end of study
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1553904
- UMLS CUI [1,2]
- C2983670
Similar models
Concomitant Medication
- StudyEvent: ODM
C2169461 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,2])
Geen commentaren